Phosphatidylinositol

Cell biology

Neuroscience

Biology

Small molecule

Surgery

Modulation (music)

Basis (linear algebra)

Signal transduction

Biochemistry

Acoustics

Computational biology

Drug discovery

Fenestration

Physics

Bioinformatics

Potassium channel

Electrophysiology

Phosphatidylinositol 4,5-bisphosphate

Mathematics

Geometry

Medicine

Biophysics

Molecular Cell

Among the five KCNQ channels, also known as the Kv7 voltage-gated potassium (Kv) channels, KCNQ2–KCNQ5 control neuronal excitability. Dysfunctions of KCNQ2–KCNQ5 are associated with neurological disorders such as epilepsy, deafness, and neuropathic pain. Here, we report the cryoelectron microscopy (cryo-EM) structures of human KCNQ4 and its complexes with the opener retigabine or the blocker linopirdine at overall resolutions of 2.5, 3.1, and 3.3 Å, respectively. In all structures, a phosphatidylinositol 4,5-bisphosphate (PIP2) molecule inserts its head group into a cavity within each voltage-sensing domain (VSD), revealing an unobserved binding mode for PIP2. Retigabine nestles in each fenestration, inducing local shifts. Instead of staying within the central pore, linopirdine resides in a cytosolic cavity underneath the inner gate. Electrophysiological analyses of various mutants corroborated the structural observations. Our studies reveal the molecular basis for the modulatory mechanism of neuronal KCNQ channels and provide a framework for structure-facilitated drug discovery targeting these important channels.

Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs